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Abstract
Dietary intake influences gut microbiota activity. Nevertheless, there is a lack of evidence available that illustrates the acute effects of
high glucose meal on metabolic endotoxemia. The present study assessed the acute impact of high glucose meal on endotoxemia
and other clinical parameters in Saudi females with varying degrees of glycemia.
The subjects were 64 consenting pre-menopausal women, grouped into 3: control [n=14 lean, non-T2DM, BMI=22.2±2.2kg/
m2]; overweight [n=16, non-T2DM, BMI=28.5±1.5kg/m2] and T2DM [n=34, BMI=35.2±7.7kg/m2]. After an overnight fast, all
subjects were given a standardized high-glucose (75g) meal. Anthropometrics were taken and blood samples were withdrawn at
baseline and postprandial (0, 2 and 4-hours), serum glucose, endotoxin and lipid profile were quantified.
At baseline, total cholesterol, LDL-cholesterol, triglycerides and serum glucose levels were significantly higher (P values <.01)
whereas significantly lower HDL-cholesterol levels (P< .01) were observed in T2DM subjects compared to other groups. Baseline
endotoxin levels were highest in the overweight group (3.2±1.1mmol/L) as compared to control (2.0±0.5mmol/L) and T2DM (2.7±
1.2 mmol/L) (P= .046). HDL-cholesterol, LDL-cholesterol and triglycerides, significantly decreased in the T2DM group after 2hours
(P values<.05), whereas unremarkable changes observed in other groups. Lastly, endotoxin levels significantly increased only in the
overweight group (3.2±1.1 vs 4.2±1.4 mmol/L; P< .05), 4hours postprandial.
High glucose meal elevates endotoxemia only among overweight subjects and impairs dysbiosis.
Abbreviations: BMI = body mass index, CBCD = chair for biomarkers of chronic diseases, GLM = general linear model, HDL =
high-density lipoprotein cholesterol, KSA = Kingdom of Saudi Arabia, LAL = limulus amebocyte lysate, LDL= low-density lipoprotein
cholesterol, LPS= lipopolysaccharides, PCC= primary care center, SPSS= statistical package for the social sciences, T2DM= type
2 diabetes mellitus, USA = United States of America, WHR = waist-hip ratio.
Keywords: Arab women, endotoxin, high sugar meal, metabolic endotoxemia
1. Introduction
The prevalence of obesity and diabetes across the globe has
become the most devastating health impediments that have
progressively increased over a decade.[1–3] Numerous studies
have endorsed that genetics, lifestyle, dietary habits and
environmental factors play a major role in their pathogene-
sis.[4–6] In recent years, mounting evidence has highlighted that
the fluctuations in the gut microbiota (dysbiosis) cause an
exponential increase in bacterial endotoxin [lipopolysaccharides
(LPS)] levels, which potentiate some inflammatory markers
thought to underpin a number of common metabolic diseases.[7–
10] Endotoxin translocates from the “leaky” gut lumen to the
blood, leading to a condition termed “metabolic endotoxe-
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mia,”[11] and elevated circulatory endotoxin levels are associated
with an array of chronic non-communicable diseases like type 2
diabetes mellitus (T2DM),[12] obesity,[13,14] atherosclerosis[15,16]
and liver disease.[17] Concurrently, several studies have examined
the impact of pre-/probiotics on gut microbiota or endotoxins
levels and related metabolic diseases.[7,18,19] Furthermore,
biomedical industries have shown an intensive commercial
interest in the role of the human microbiome and factors
alleviating it, by using pre-/pro-biotics.[20,21]
It is well known that diet and feeding habits appear to play a
predominant role inmodulating endotoxin levels over the courseof
the day.[22,23] Our previous study pointed out that metabolic
endotoxemia facilitated by high-fat meal has been exacerbated in
subjects with T2DM, accompanied by a parallel rise in cardio-
metabolic risk profile compared to their healthy counterparts.[24]
This cardiometabolic profile includes lipids such as triglycerides,
LDL- andHDL-cholesterol, levels of which are significantly linked
to endotoxin-induced sub-chronic inflammation observed in
patients with metabolic diseases.[24] To the best of our knowledge,
the effect of high–glucose feed on the metabolic endotoxemia,
however, remains to be fully understood. Hence, the current study
sought to determine the postprandial effects of a high-glucose diet
on endotoxemia and other serological parameters in adult Saudi
T2DM, overweight females with their healthy counterparts.
2. Materials and methods
2.1. Participant and study design
In this observational study, 64 Saudi pre-menopausal women
were randomly recruited from different primary care centres
(PCCs) in Riyadh, Saudi Arabia. A research team member was
deployed to each PCC with full knowledge of the protocol to be
shared with the assigned PCC physician and nurse. The study has
been approved by the Ethics Committee of the College of
Medicine King Saud University (No. 10–173), Riyadh, Saudi
Arabia, prior to the commencement of the research and all
patients gave written consent.
2.2. Exclusion criteria
Subjects with chronic conditions such as asthma, hypertension,
history of cardiac, kidney or liver disease, in addition, subjects
with known long-standing diabetes and/or receiving anti-diabetic
medication, those with fasting glucose levels >11 mmol/L, or
with fasting triglycerides levels >4 mmol/L were excluded from
the study.
2.3. Anthropometry and blood collections
Subjects were requested to visit their respective PCCSs after an
overnight fast (≥10 hours). Fasting blood samples were collected
at baseline to determine subjects eligibility for the study and to
assess glucose control as well as lipid profiles. Weight (kg) and
height (cm) were recorded using an international standard scale
(Digital Pearson Scale, ADAM Equipment Inc., (USA)). Waist
circumference was measured at the level of the iliac crest at the
end of normal respiration, and hip circumference was measured
at the widest circumference around the buttocks using a
measuring tape and body mass index (BMI) was calculated as
kg/m2, as well as waist-to-hip ratios (WHR) were calculated.
Blood pressure (mm Hg) was measured twice using a calibrated,
mercurial sphygmomanometer, with a 15-minute interval. The
mean of the 2 readings was recorded. Based on BMI and DM
status, consenting participants were categorized into 3 groups:
Control (14 lean, non- T2DM) subjects with body mass index
(BMI) 22.1±2.4kg/m2, range 7.8; overweight (n=16) with 28.5
±1.5kg/m2, range 3.6 and subjects with early onset of T2DM
(BMI: 35.1±9.0kg/m2; range 35.2, n=34).
2.4. High oral glucose load
Subjects were asked to return the following day, again in a fasted
state, to their respective PCC for intervention. Subjects were given
a high-glucose meal similar to oral glucose tolerance test (75g of
sugar dissolved in water). They were instructed to fully consume
the liquid provided immediately following baseline blood
extraction. Blood samples were drawn via peripheral venous
can-nula and a flushing line was added to maintain vein patency
since blood was collected serially at baseline (0hours), after 2
hours and 4hours. Blood samples were collected and transferred
to a non-heparinized tube for centrifugation. Collected serum
samples were transferred to pre-labelled plain tubes, placed on ice
and delivered to the chair for Biomarkers of Chronic Diseases
(CBCD) laboratory in King Saud University, Riyadh, KSA, for
storage at 20°C. All participants were given tokens of
appreciation for their participation in the study.
2.5. Assessment of biochemical profile
Serum glucose and lipid profile were measured routinely using an
autoanalyzer (Konelab, Espoo, Finland). Serum endotoxin was
analyzed using a commercially available QCL-1000 LAL End
Point.
2.6. Data analysis
All statistical analyses were conducted using SPSS version 22.0
(SPSS, Chicago, IL, USA). All continuous variables were
presented as mean± standard deviation and were normalized
prior to parametric analyses. For comparison between groups,
the univariate general linear model (GLM) was used with
Bonferroni post-hoc comparisons. Age and BMI were used as
covariates. For comparison between pre- and post-intervention,
paired T-test was used for normally distributed variables and
Wilcoxon Signed Ranks test for endotoxin. Bivariate linear
regression analysis was used to determine associations between
endotoxin variables of interest. Significance was set at P< .05.
3. Results
3.1. Baseline characteristics
Table 1 shows the baseline characteristics of the 3 groups. The
T2DM subjects had significantly higher cholesterol level (5.1±
1.2mmol/L), which was significantly higher from the cholesterol
level of control (3.8±0.4mmol/L) subjects. The concentration of
LDL cholesterol was also significantly higher in the T2DM
subjects (3.4±1.1mmol/L) as compared to Overweight (2.6±
0.8mmol/L, P value<.01) and control (2.2±0.3mmol/L, P value
<.01) subjects. However, the concentration of HDL-cholesterol
was significantly lower in T2DM (1.0±0.2mmol/L, P value
<.01) and overweight subjects (1.2±0.3mmol/L, P value <.01)
as compared to healthy (1.3±0.3mmol/L) subjects.
As expected, subjects with T2DM had significantly higher
serum glucose levels (7.3±1.8mmol/L) than the overweight+
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(4.5±0.5mmol/L, P< .01) and control subjects (4.4±0.3mmol/
L, P< .001). The subjects with T2DM also had significantly
higher serum triglycerides (1.6±0.6mmol/L). Furthermore,
endotoxin levels of the overweight subjects (3.2±1.1) were
significantly higher than control subjects (2.0±0.5). However,
the endotoxin level of T2DM subjects (2.7±1.2) was not
significantly different from either control or overweight subjects.
3.2. Effects of high glucose load
Table 2 shows the changes in glucose, lipid and endotoxin
profiles of all groups after adjusting for age and metformin. The
glucose response to a glucose load was expected to increase in
all groups after 2hours with a concomitant decrease after 4
hours. Among the lipids, there were no significant changes
observed in either the control or overweight groups. In the
T2DM group, no significant differences in total cholesterol and
LDL-cholesterol levels were observed. However, HDL-choles-
terol significantly increased in the T2DM group at 4hours as
compared to baseline (P< .05) and 2-hours levels (P< .05).
Furthermore, triglycerides concentration also increased signifi-
cantly at 4-hours as compared to 2-hours level (P< .05).
Finally, endotoxin levels significantly increased in the over-
weight group at 2-hours and 4-hours as compared to baseline
endotoxin after adjusting for age and use of metformin
(P< .05). No significant changes in endotoxin levels were
observed in both the control and T2DM group.
3.3. Associations of endotoxins over measured variables
over time
Table 3 shows the bivariate associations of endotoxin to glucose
and lipids over time. Endotoxin was negatively associated with
LDL-cholesterol only in the overall group and this was observed
at 2-hour (R=0.37; P< .05) (Fig. 1). The rest of the
associations were non-significant.
4. Discussion
The main finding in the present study is that circulating levels of
endotoxin are elevated after a high glucose meal among
overweight non-T2DM subjects and these unfavorable changes
were not observed among non-overweight, non-T2DM as well as
T2DM subjects. The significant increase of endotoxin levels
among overweight subjects suggests exacerbation of an already
dysfunctional gut among these subjects. Physiologically, endoge-
nous insulin released into the circulation as a response to acute
hyperglycemia.[25] During this process and in the presence of a
healthy gut such as the case of controls in the present study, no
aberrant changes will be observed in endotoxin levels. In the case
of overweight subjects, however, the significant increase in
endotoxin levels following a high glucose load implicates the
presence of insulin-resistance and probably systemic low-grade
chronic inflammation within this cohort, making the leaky gut
even leakier. Chronic exposure to endotoxinmay increase T2DM
risk since higher levels of endotoxin, in general, is associated with
insulin resistance.[11] However, only a few studies have evaluated
the influence of nutrients and/or specific food types on
endotoxemia.[26]
In our study, endotoxin levels following a high-glucose meal
showed a dramatic increase only in the overweight and not in the
T2DM group. Among several possibilities, is the lack of any
reduction in endotoxin levels in the T2DM group may be due to
the differences in the subjects dietary make-up. The main effect,
however, might be the medications that this group has been
taking which include metformin. Metformin has been shown to
drastically improve the gut microbiota composition among
T2DM.[5,27,28] This could probably explain why endotoxin at
baseline for the T2DM group is much lower than the overweight
group and why the response to a glucose load was almost as
similar to controls. The significant increase in endotoxin
observed in the overweight group can be explained by an
already existing insulin-resistant state in the subjects, as
evidenced by the modest but significantly higher baseline
endotoxin levels compared to other groups.
Finally, in the present study, we observed a significant inverse
association between endotoxin and post-prandial LDL-choles-
terol. While no significant differences were observed between
Table 2
Metabolic changes pre- and post-prandial high-glucose load.
Group 0 – Hour 2 – Hour 4 – Hour
Total Cholesterol (mmol/L)
Control 3.8±0.4 3.9±0.6 3.8±0.5
Overweight 4.3±1.0 4.3±1.0 4.4±1.1
T2DM 5.1±1.2 4.9±1.1 5.1±1.2
Glucose (mmol/L)
∗
Control 4.4±0.3 6.0±1.4 4.7±1.5
Overweight 4.5±0.5 5.8±2.1 4.6±2.9
T2DM 7.3±1.8 13.4±4.5A 7.6±4.3B
High-density lipoprotein cholesterol (mmol/L)
Control 1.3±0.3 1.3±0.3 1.3±0.2
Overweight 1.2±0.3 1.2±0.3 1.2±0.3
T2DM 0.97±0.18 0.95±0.18 1.01±0.21AB
Low-density lipoprotein cholesterol (mmol/L)
Control 2.2±0.3 2.2±0.3 2.2±0.3
Overweight 2.6±0.8 2.6±0.8 2.7±0.9
T2DM 3.4±1.1 3.2±0.9 3.3±1.0
Triglycerides (mmol/L)
∗
Control 0.7±0.2 0.7±0.4 0.7±0.3
Overweight 1.1±0.7 1.1±0.7 1.1±0.7
T2DM 1.57±0.60 1.49±0.61 1.64±0.71B
Endotoxin (EU/ml)
∗
Control 2.0±0.5 2.1±0.4 1.6±0.7
Overweight 3.2±1.1 4.0±1.0A 4.2±1.4A
T2DM 2.7±1.2 2.5±1.3 2.9±1.6
Data presented in terms of Mean±SD, Superscript A and B indicate a significant difference from 0-
hours and 2-hours.
∗
denotes non-normal variables; P value significant at <.05.
Table 1
Clinical characteristics of subjects according to the groups.
Parameters Control Overweight T2DM P value
N 14 16 34
Age (years) 23.2±8.4 33.7±7.6A 40.5±5.9AB <.001
BMI (kg/m2) 22.1±2.4 28.9±1.3A 35.1±9.0AB <.001
Glucose (mmol/L)
∗
4.4±0.3 4.5±0.5 7.3±1.8AB <.001
Total Cholesterol (mmol/L) 3.8±0.4 4.3±1.0 5.1±1.2A <.001
Triglycerides (mmol/L)
∗
0.7±0.2 1.1±0.7 1.6±0.6AB <.001
HDL-Cholesterol (mmol/L) 1.3±0.3 1.2±0.3 1.0±0.2AB <.001
LDL-Cholesterol (mmol/L) 2.2±0.3 2.6±0.8 3.4±1.1AB <.001
Endotoxin (mmol/L)
∗
2.0±0.5 3.2±1.1A 2.7±1.2 .046
Data presented in terms of Mean±SD.
∗
denotes non-normal variables, and Superscript A and B indicate a significant difference at 0.05 level
from Normal and Overweight respectively.
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LDL-cholesterol over time in all groups, most studies indicate
LDL-cholesterol levels to be lower postprandial as compared to
fasting levels, at least in people with T2DM or with insulin
resistance.[29] This could explain why increasing endotoxin
levels, particularly in the overweight and T2DM groups,
translated to lower LDL-cholesterol levels over-all. The lack of
associations between endotoxin and other cardiometabolic
parameters in the present study does not supersede our previous
findings on the strong relationship between endotoxin and these
measures after high fat intake,[30] and the lack of associations
may be due to the sample size issues.
The authors acknowledge some limitations and these include
the small sample size and other factors not documented in the
study such as lifestyle and mode of nutrition, which can
significantly modify the gut microbiome. Further and longer
prospective investigations using the full components of metabolic
syndrome,[31] with a larger number of subjects and inclusion of
more inflammatory markers may provide clear insights into how
glucose-induced endotoxemia affect the over-all metabolic
picture of non-T2DM overweight subjects. Lastly, Arab women
are more prone to develop obesity secondary to religious and
cultural norms prevalent in the region, making them at higher risk
for T2DM and therefore the study focused on this population.
Whether the same altered endotoxin levels apply to men of
varying glycemic levels need to be investigated separately. The
study is nevertheless the first to explore the effects of high glucose
Table 3
Bivariate associations between lipids, glucose and endotoxin.
Time (Hour) Total Cholestrol (mmol/L) Glucose (mmol/L)
∗
HDL-Cholestrol (mmol/L) LDL-Cholestrol (mmol/L) Triglycerides (mmol/L)
∗
Overall (N=64)
0 – Hour 0.04 0.17 0.26 0.12 0.12
2 – Hour 0.24 0.25 0.21 0.37† 0.10
4 – Hour 0.09 0.21 0.11 0.16 0.27
Control (N=14)
0 – Hour 0.43 0.49 0.42 0.27 0.40
2 – Hour 0.20 0.37 0.47 0.43 0.37
4 – Hour 0.33 0.07 0.29 0.36 0.19
Overweight (N=16)
0 – Hour 0.13 0.46 0.48 0.06 0.46
2 – Hour 0.21 0.43 0.25 0.61 0.43
4 – Hour 0.23 0.37 0.05 0.05 0.28
T2DM (N=34)
0 – Hour 0.04 0.36 0.15 0.04 0.23
2 – Hour 0.19 0.03 0.11 0.28 0.17
4 – Hour 0.16 0.37 0.05 0.27 0.36
Data presented as Spearman correlation coefficient.
∗
denotes non-normal variables.
† denotes P value <.05.
Figure 1. Correlation between log LDL-cholesterol (mmol/L) and Log Endotoxin (EU/ml) at 2-hours in overall patients.
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load in endotoxin levels among Arab ethnic women with varying
levels of glycemia. This has clinical implications, especially in the
region where the concept of gut microbiota and endotoxin in
particular, and how it affects obesity-related diseases, remain to
be explored.
5. Conclusions
In conclusion, an acute high glucose load promotes endotoxemia
among overweight subjects and exacerbates dysbiosis. This effect
is not observed among T2DM patients on metformin as well as
non-obese, non-T2DM subjects.
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